First Trust Direct Indexing’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,887
Closed -$2.62M 175
2024
Q3
$2.62M Buy
11,887
+2,238
+23% +$463K 0.14% 143
2024
Q2
$1.9M Buy
9,649
+537
+6% +$111K 0.12% 176
2024
Q1
$1.96M Buy
9,112
+804
+10% +$169K 0.15% 145
2023
Q4
$1.75M Buy
8,308
+1,301
+19% +$278K 0.16% 142
2023
Q3
$1.4M Buy
7,007
+633
+10% +$126K 0.16% 145
2023
Q2
$1.18M Sell
6,374
-678
-10% -$125K 0.13% 174
2023
Q1
$1.35M Buy
7,052
+945
+15% +$171K 0.16% 154
2022
Q4
$1.03M Buy
6,107
+164
+3% +$28.5K 0.14% 191
2022
Q3
$1.05M Sell
5,943
-240
-4% -$47.4K 0.15% 175
2022
Q2
$1.27M Buy
6,183
+230
+4% +$48.8K 0.18% 145
2022
Q1
$1.42M Buy
5,953
+626
+12% +$147K 0.17% 141
2021
Q4
$1.22M Buy
5,327
+52
+1% +$11.4K 0.16% 151
2021
Q3
$1.02M Buy
5,275
+534
+11% +$108K 0.15% 167
2021
Q2
$1.01M Buy
4,741
+1,307
+38% +$276K 0.15% 172
2021
Q1
$701K Buy
3,434
+233
+7% +$45.9K 0.19% 156
2020
Q4
$583K Buy
+3,201
New +$544K 0.16% 163

Other funds holding CME

First Trust Direct Indexing's CME Position: Q4 2024 in Review

First Trust Direct Indexing sold out of CME Group (CME) in Q4 2024, closing a stake of 11,887 shares — an estimated $2.62M sold.

First Trust Direct Indexing first reported a position in CME in Q4 2020 and held it in 16 quarters. The position peaked at $2.62M in Q3 2024. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

  • First Trust Direct Indexing reported no remaining CME Group position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 11,887 CME Group shares in Q4 2024, an estimated $2.62M.
  • First Trust Direct Indexing first reported a position in CME Group in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's CME Group position peaked at $2.62M in Q3 2024.
  • 1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.